Payer Strategy Lead
Pricing and Market Access Support
Needed to develop pricing and market access estimates for a biologic with expected follow-on indications
After completion of Phase II studies for an internal program a payer strategy lead needed to develop robust pricing and market access assumptions for a biologic product to inform strategic forecasting efforts.
ClearView has deep subject matter expertise within the pricing and market access space and has experience utilizing these projects as a bridge into broader commercial strategy development in preparation for the launch of innovative products.